Rotavirus vaccines completed dose (RotaC) immunization coverage among in Guyana
Guyana: Rotavirus vaccines completed dose (RotaC) immunization coverage among was 99.0% in 2025. ◆ Volatile
Rotavirus vaccines completed dose (RotaC) immunization coverage among in Guyana, 2006–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, rotavirus vaccines completed dose (rotac) immunization coverage among in Guyana stood at 99.0%. That is the highest value across all 20 years on record.
Compared with earlier readings it is up 5.3% on the previous year and up 3.1% over ten years.
Over the whole period, rotavirus vaccines completed dose (rotac) immunization coverage among in Guyana peaked at 99.0% in 2019 and was at its lowest, 0.0%, in 2006.
Guyana ranks 1st of 194 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Rotavirus vaccines completed dose (RotaC) immunization coverage among in Guyana, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 39.0% | — |
| 2011 | 77.0% | +97.4% |
| 2012 | 91.0% | +18.2% |
| 2013 | 94.0% | +3.3% |
| 2014 | 95.0% | +1.1% |
| 2015 | 96.0% | +1.1% |
| 2016 | 96.0% | +0.0% |
| 2017 | 97.0% | +1.0% |
| 2018 | 91.0% | -6.2% |
| 2019 | 99.0% | +8.8% |
| 2020 | 97.0% | -2.0% |
| 2021 | 93.0% | -4.1% |
| 2022 | 99.0% | +6.5% |
| 2023 | 99.0% | +0.0% |
| 2024 | 94.0% | -5.1% |
| 2025 | 99.0% | +5.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 4 |
| 2010s | 87.5% | 39.0% | 99.0% | 10 |
| 2020s | 96.8% | 93.0% | 99.0% | 6 |
Countries ranked near Guyana
- 1 Uzbekistan 99.0% compare
- 1 El Salvador 99.0% compare
- 1 Tuvalu 99.0% compare
- 1 Seychelles 99.0% compare
- 1 Oman 99.0% compare
More health data for Guyana
- Un projection of annual infant deaths, annual growth rate -1.59 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4509 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,225 deaths per 1,000 people (2090)
- Number of infants who die before age 1 62 deaths (2100)
- Population ages 0-14, female, annual growth rate -0.1985 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1425 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.1895 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1468 units per person (2025)
Frequently asked questions
- What is rotavirus vaccines completed dose (rotac) immunization coverage among in Guyana?
- Rotavirus vaccines completed dose (rotac) immunization coverage among in Guyana was 99.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest rotavirus vaccines completed dose (rotac) immunization coverage among recorded in Guyana?
- The highest recorded value was 99.0% in 2019.
- What is the lowest rotavirus vaccines completed dose (rotac) immunization coverage among recorded in Guyana?
- The lowest recorded value was 0.0% in 2006.
- How does Guyana rank for rotavirus vaccines completed dose (rotac) immunization coverage among?
- Guyana ranks 1st out of 194 countries with data for 2025.
- Is rotavirus vaccines completed dose (rotac) immunization coverage among rising or falling in Guyana?
- Over the last ten years it is up 3.1%. The long-run trend across the full record is volatile.
- Where does this Guyana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).